Showing results (81-90 of 272) with videos related to
Sort By:
Pageof 28
Human Immunology|April 1, 1987
Characterization of mononuclear cell subpopulations in normal fetal peripheral bloodM Rainaut, M Pagniez, T Hercend, et al.Human Immunology|November 1, 1981
Comparative expression of T9, T10, and Ia antigens on activated human T cell subsetsT Hercend, J Ritz, S F Schlossman, et al.The Journal of Clinical Investigation|March 1, 1996
Clonal T cell expansion induced by interleukin 2 therapy in blood and tumorsA Kumar, F Farace, C Gaudin, et al.Immunogenetics|June 20, 1998
Regulation of expression of the human lymphocyte activation gene-3 (LAG-3) molecule, a ligand for MHC class IID Bruniquel, N Borie, S Hannier, et al.Klinische Wochenschrift|December 2, 1985
Functional surface structures on human natural killer cellsR E Schmidt, T Hercend, S F Schlossman, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1998
CD3/TCR complex-associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signalingS Hannier, M Tournier, G Bismuth, et al.European Journal of Immunology|October 10, 2001
LAP, a lymphocyte activation gene-3 (LAG-3)-associated protein that binds to a repeated EP motif in the intracellular region of LAG-3, may participate in the down-regulation of the CD3/TCR activation pathwayN Iouzalen, S Andreae, S Hannier, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1991
Further evidence for a gamma/delta T cell receptor-mediated TCT.1/CD48 recognitionF Mami-Chouaib, P Del Porto, D Delorme, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1983
Characterization of an antigen expressed by human natural killer cellsJ D Griffin, T Hercend, R Beveridge, et al.The Journal of Investigative Dermatology|September 1, 1991
Tumor-infiltrating CD3- NK cells are more effective than CD3+ T cells in killing autologous melanoma cellsO Azogui, M F Avril, A Margulis, et al.Pageof 28